FDA Updates
En EspanolEn Espanol

Search Results - Page 1 of about 312 results

Acomplia New Drug Application News, 23 June 2005
Zimulti (rimonabant) is a new drug in development for the treatment of obesity and overweight patients with associated risk factors. Zimulti information includes news, clinical ...
New Drug Applications (FDA)
News: Rimonabant: Sustained Weight Loss, Improved Blood Profiles - Drugs ...
Taking the investigational drug rimonabant (brand name Acomplia) produces modest, sustained weight loss and improved blood markers after two years, according to
News & Articles (Drugs.com)
Acomplia New Drug Application News, 26 March 2007
Zimulti (rimonabant) is a new drug in development for the treatment of obesity and overweight patients with associated risk factors. Zimulti information includes news, clinical ...
New Drug Applications (FDA)
Acomplia New Drug Application News, 14 November 2007
Zimulti (rimonabant) is a new drug in development for the treatment of obesity and overweight patients with associated risk factors. Zimulti information includes news, clinical ...
New Drug Applications (FDA)
Clinical Trials: Rimonabant Effectively Reduces Visceral Fat in the Obese Patient ...
PARIS, Sept. 19, 2007-The first direct evidence of the effects of Acomplia (rimonabant) in significantly reducing human visceral fat (the metabolically active f
Clinical Trial Results (FDA)
Acomplia Consumer Information
Rimonabant Accepted for Filing By the FDA June 23, 2005 Sanofi-aventis Received from the FDA an Approvable Letter for Rimonabant for Weight Management and a Non Approvable Letter for ...
Consumer Information (Drugs.com)
Clinical Trials: Mixed Results in Clinical Trial of Weight Loss Drug Rimonabant on ...
CHICAGO, April 1, 2008 The anti-obesity medication rimonabant showed mixed results in slowing progression of coronary artery disease in patients with abdominal
Clinical Trial Results (FDA)
Acomplia User Reviews
User Reviews for Acomplia. The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the ...
User Reviews (Drugs.com)
Tenuate Dospan Drug Interactions
217 medications are known to interact with Tenuate Dospan. Includes Acomplia (rimonabant), Adderall XR (amphetamine/dextroamphetamine), amitriptyline.
Drug Interactions (Cerner Multum)
Obesity Medication
December 8, 2006 - Rimonabant Update in the United States; February 17, 2006 - Sanofi-aventis Received from the FDA an Approvable Letter for Rimonabant for Weight Management and a ...
Drugs by Condition (Drugs.com)
1 2 3 4 5 6 7 8 9 10
(web2)